VIVA Biotech Holdings
HKEX:1873
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
VIVA Biotech Holdings
HKEX:1873
|
CN |
|
Y
|
Yinfu Gold Corp
OTC:ELRE
|
CN |
|
Svenska Cellulosa SCA AB
STO:SCA B
|
SE |
VIVA Biotech Holdings
Viva Biotech Holdings engages in preclinical research and development of innovative drugs. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2019-05-09. The firm is principally engaged in the provision of the structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide for their pre-clinical stage innovative drug development. The Company’s core technologies include structure-based drug discovery (SBDD) platform, fragment-based drug discovery (FBDD) platform, affinity selection mass spectrometry (ASMS) screening platform and membrane protein targeted drug discovery platform. The firm operates its businesses mainly in the United States, China, Europe and other regions.
Viva Biotech Holdings engages in preclinical research and development of innovative drugs. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2019-05-09. The firm is principally engaged in the provision of the structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide for their pre-clinical stage innovative drug development. The Company’s core technologies include structure-based drug discovery (SBDD) platform, fragment-based drug discovery (FBDD) platform, affinity selection mass spectrometry (ASMS) screening platform and membrane protein targeted drug discovery platform. The firm operates its businesses mainly in the United States, China, Europe and other regions.
